La Renon

Ahmedabad, India Founded: 2007 • Age: 19 yrs Minicorn
Pharmaceutical products for chronic disease management are provided.

About La Renon

La Renon is a Healthcare company based in Ahmedabad (India) founded in 2007 by Pankaj Singh. Pharmaceutical products for chronic disease management are provided. La Renon has raised $115.63 million across 3 funding rounds from investors including Peak XV Partners, A91 Partners and ChrysCapital. The company has 3,082 employees. La Renon has completed 1 acquisition, including Enaltec Labs. La Renon was last valued at $124.64 million in June 2015. Its chief executive, as recorded, is Pankaj Singh. Its website larenon.com draws about 13 thousand monthly visits. Its Indian entity La Renon Healthcare Private Limited reported revenue of ₹1,439 Cr. La Renon offers products and services including Nephroscience Products and Critical Care Products. Its focus areas include Traditional Pharmaceuticals, Generics and Therapeutic Areas.

Company details

La Renon was founded in 2007 in Ahmedabad, India, as a provider of pharmaceutical products. Operations are centered on chronic disease management across therapeutic areas including nephrology, neurology, urology, critical care, gastroenterology, respiratory, and cardiac metabolism such as hypertension and diabetes. A CNS division addresses severe conditions like epilepsy, Alzheimers, Parkinsons, and neuropathic pain. The company operates within the healthcare sector, focusing on product development and distribution.

  • Headquarters Ahmedabad, India
  • Employees 3,082
  • Founders Pankaj Singh
  • Stage Minicorn
  • Sectors
    Healthcare
  • Website category Health · Pharmacy
  • Phone
    •••• ••••
  • Website larenon.com
  • Social LinkedIn X Facebook
  • Legal Name La Renon Healthcare Private Limited
  • Date of Incorporation 07 Aug, 2007
  • Jurisdiction Ahmedabad, Gujarat, India
Key Metrics
  • Annual Revenue
    ₹1,439 Cr

    FY 2025 · +16% YoY

  • Net Profit
    ₹248 Cr

    FY 2025 · 15% margin

  • EBITDA
    ₹386 Cr

    FY 2025 · 23% margin

  • Total Equity Funding
    $115.63M (USD)

    in 3 rounds

  • Latest Funding Round
    $70M (USD), Series C

    Apr 2024

  • Investors
  • Employee Count
    3,082
  • Investments & Acquisitions

Products & Services of La Renon

La Renon offers a comprehensive portfolio of products and services, including Nephroscience Products and Critical Care Products.

Nephroscience Products
Pharmaceuticals

Products for chronic kidney disease management are provided in the therapeutic segment

Critical Care Products
Pharmaceuticals

High-quality anti-infectives for ICUs and trauma centers are supplied across India

Funding Insights of La Renon

La Renon has successfully raised a total of $115.63M across 3 strategic funding rounds. The most recent funding activity was a Series C round of $70 million completed in April 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $115.63M
  • Total Rounds 3
  • Last Round Series C — $70M
  • First Round $15.63M

    (Jun 2015)

  • Investors Count 3

All 3 funding rounds of La Renon with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Apr 2024$70MSeries C––
Jan 2021$30MSeries B–A91 Partners
–
Jun 2015$15.63MSeries A$124.64MPeak XV Partners
–
Valuation history
DateValuationStage
Jun 2015$124.64M••••••••

Last known valuation $124.64M (Jun 2015). 3 investors in total: 3 institutional.

Investors in La Renon

La Renon has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Peak XV Partners, A91 Partners and ChrysCapital.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Investment partnerships and support for founders in software, financial services, and consumer sectors.
2018a91partners.comMumbai, India
Venture capital firm investing in startups and providing support programs.
2000peakxv.comBengaluru, India
Investment firm focusing on private equity in sectors like financial services and healthcare.
1999chryscapital.com
Premium access

Investor details for La Renon

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of La Renon Healthcare Private Limited (La Renon)

La Renon Healthcare Private Limited is the primary company behind La Renon. The board of La Renon Healthcare Private Limited currently have 8 directors; the longest-serving is Samir Kumar, appointed in 2007. 10 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Samir Kumar
DIN 01647790
Director07 Aug 200719 yrs 3 moLa Renon Healthcare Private Limited
Pankaj Kumar Singh
DIN 01721388
Managing Director01 Sep 200719 yrs 2 moLa Renon Healthcare Private Limited
Vivek Gupta
DIN 02334674
Director01 Nov 200818 yrsLa Renon Healthcare Private Limited
Bharat Singh
DIN 08222884
Nominee Director27 May 20206 yrs 5 moLa Renon Healthcare Private Limited
Bharadwaj Thiruvenkata Venkatavaraghavan
DIN 02918495
Nominee Director28 Jan 20215 yrs 9 moLa Renon Healthcare Private Limited
Nihit Duggal
DIN 06563271
Director03 Jun 20233 yrs 5 moLa Renon Healthcare Private Limited
Kshitij Pankaj Sheth
DIN 00125058
Nominee Director16 Apr 20242 yrs 7 moLa Renon Healthcare Private Limited
Anshul Agarwal
DIN 07329252
Nominee Director19 Nov 202511 moLa Renon Healthcare Private Limited

People of La Renon

5 people are tracked at La Renon (5 in leadership); the tracked headcount is 3,082.

NameRoleGroup
Founder & CEOLeadership
Senior Vice PresidentLeadership
Senior Vice PresidentLeadership
Yashwant Singh
Senior Vice PresidentLeadership
Abhijit Basu
Vice PresidentLeadership
Premium access

Complete people profiles for La Renon

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of La Renon

Figures of La Renon Healthcare Private Limited, the primary company behind La Renon, for FY 2025. Revenue was ₹1,439 Cr (+16% year on year). Net profit was ₹248 Cr (15% margin). EBITDA was ₹386 Cr (23% margin). Revenue has grown at a compounded annual rate of +26% over three years and +19% over five years.

  • ₹1,439 CrRevenue · FY 2025 · +16% YoY
  • ₹248 CrNet profit · 15% margin
  • ₹386 CrEBITDA · 23% margin
  • ₹49.68 CrPaid-up capital
  • 2,727Employees (provident fund records)
  • +26%Revenue CAGR, 3 years
  • +19%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of La Renon Healthcare Private Limited are on its company page.

Premium access

Detailed financial statements for La Renon

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Investments & Acquisitions by La Renon

La Renon has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Enaltec Labs.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Non-oncology APIs are developed and manufactured by Enaltec Labs.
enaltec.comMumbai, India2006Jan 2022••••
Premium access

Complete acquisition details for La Renon

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of La Renon

5 dated milestones of La Renon across 17 years, from founding to its latest funding, stage changes and deals.

  1. Founded La Renon is founded.
  2. Funding First funding round of $15.6M.
  3. Milestone Reaches Minicorn status.
  4. Acquisition Acquires Enaltec Labs.
  5. Funding Latest funding round, Series C, of $70.0M.

Web traffic of La Renon

The website of La Renon (larenon.com) receives about 12.7K visits a month and ranks #1,761,991 among all websites worldwide, #2,592 in Pharmacy.

  • Monthly visits
    12.7K

    ▼ 22.3% vs previous month

  • Unique visitors
    5.6K

    per month

  • Global rank
    #1,761,991

    among all websites

  • Category rank
    #2,592

    Health · Pharmacy

Similar websites

Websites whose visitors overlap most with La Renon. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
prograf.com
100%
#3,602,643View details
isn-india.org
isn-india.org
66%
#2,082,227–
renalnutrition.org
63%
#13,541,125View details
dawaadost.com
59%
105.4K#297,555View details
mrmed.in
57%
432.6K#85,983View details
••••••••••••••••.com••%•.•M#•••••–
Premium access

All 6 similar websites and full traffic analytics for La Renon

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 6 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Traditional Health & Nutrition

3 companies that operate in the same segment as La Renon (Traditional Health & Nutrition) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Oral solid drug delivery systems are manufactured and developed.
1985Mumbai, Maharashtra, IndiaUSD 42.49 MUSD 72.52 M1,115
Generic, semi-solid, and liquid dosage forms are manufactured.
1990Bengaluru, Karnataka, IndiaUSD 508.93 M4,050
Specialty generic pharmaceuticals and APIs are manufactured and marketed.
1983Mumbai, Maharashtra, IndiaUSD 6.44 B19,801
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about La Renon

Premium access

Complete news archive for La Renon

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about La Renon

La Renon was founded in 2007 and raised its 1st funding round 8 years after it was founded.

La Renon is headquartered in Ahmedabad, India. It is registered at Ahmedabad, Gujarat, India.

Pankaj Singh is the CEO of La Renon, as recorded in our data. They have also founded this company.

La Renon is a funded company, having raised a total of $115.63M across 3 funding rounds to date. The company's 1st funding round was a Series A of $15.63M, raised on Jun 2015.

La Renon has 3,082 employees.

The primary company behind La Renon, La Renon Healthcare Private Limited, reported revenue of ₹1,439 Cr for FY 2025, up 16% year on year.

La Renon was founded in 2007 in Ahmedabad, India, as a provider of pharmaceutical products. Operations are centered on chronic disease management across therapeutic areas including nephrology, neurology, urology, critical care, gastroenterology, respiratory, and cardiac metabolism such as hypertension and diabetes. A CNS division addresses severe conditions like epilepsy, Alzheimers, Parkinsons, and neuropathic pain. The company operates within the healthcare sector, focusing on product development and distribution.

La Renon offers Nephroscience Products and Critical Care Products.

La Renon has made 1 acquisition, including Enaltec Labs.

La Renon has 3 investors. Key investors include Peak XV Partners, A91 Partners, and ChrysCapital.

The valuation of La Renon is $124.64M as of Jun 2015.

La Renon operates through La Renon Healthcare Private Limited.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available